rosiglitazone has been researched along with int 131 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aramaki, H; Beckmann, H; Biermann, D; Chen, JL; Cushing, TD; Flygare, J; Frankmoelle, W; Furukawa, N; Hagiwara, A; Houze, JB; Iida, T; Jaen, J; Kearney, P; Kitao, Y; Learned, MR; Li, Y; Lindstrom, M; Liu, J; McGee, LR; Miao, S; Motani, A; Nakamura, M; Nishiu, J; Rubenstein, SM; Shinkai, H; Taygerly, JP; Thoolen, M; Timmermans, PB; Walker, N; Wang, Z; Weiszmann, J; Ye, G | 1 |
| Hashimoto, Y; Ishikawa, M; Makishima, M; Noguchi-Yachide, T; Okazaki, S; Shioi, R; Yamaguchi, T | 1 |
| Biermann, DH; Chen, JL; Fang, Z; Fuentes, H; Jaen, J; Learned, RM; Lee, G; Li, Y; Lindstrom, M; Liu, J; Liu, Q; McGee, LR; Motani, A; Staunton, J; Walker, NP; Wang, Z; Weiszmann, J | 1 |
| Depaoli, AM; Higgins, LS | 1 |
1 review(s) available for rosiglitazone and int 131
| Article | Year |
|---|---|
Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation.
Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Gluconeogenesis; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin Resistance; Pioglitazone; PPAR gamma; Quinolines; Retinoid X Receptors; Rosiglitazone; Sulfonamides; Thiazolidinediones | 2010 |
3 other study(ies) available for rosiglitazone and int 131
| Article | Year |
|---|---|
Discovery of INT131: a selective PPARγ modulator that enhances insulin sensitivity.
Topics: Administration, Oral; Animals; Binding Sites; Crystallography, X-Ray; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Half-Life; Insulin Resistance; Male; Mice; PPAR gamma; Protein Structure, Tertiary; Quinolines; Rats; Rats, Sprague-Dawley; Rats, Zucker; Structure-Activity Relationship; Sulfonamides | 2013 |
Structure-activity relationship studies of non-carboxylic acid peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists.
Topics: Acetamides; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Molecular Structure; PPAR alpha; PPAR delta; Structure-Activity Relationship | 2016 |
INT131: a selective modulator of PPAR gamma.
Topics: Adipocytes; Amino Acid Sequence; Animals; Blood Glucose; Cell Differentiation; Cells, Cultured; Crystallography, X-Ray; Drug Partial Agonism; Hydrophobic and Hydrophilic Interactions; Hypoglycemic Agents; Insulin; Mice; Molecular Sequence Data; PPAR gamma; Protein Binding; Quinolines; Rats; Rats, Zucker; Rosiglitazone; Sulfonamides; Thiazolidinediones | 2009 |